Evaluation of Novel Nasal Mucoadhesive Nanoformulations Containing Lipid-Soluble EGCG for Long COVID Treatment.

Nicolette FrankDouglas DickinsonGarrison LovettYutao LiuHongfang YuJingwen CaiBo YaoXiaocui JiangStephen Hsu
Published in: Pharmaceutics (2024)
The saline-based novel EC16m mucoadhesive nasal nanoformulations rapidly inactivated human coronavirus with mucociliary safety properties comparable to saline, a solution widely used for nasal applications.